334 related articles for article (PubMed ID: 27614318)
1. A Two-Week, Randomized, Double-masked Study to Evaluate Safety and Efficacy of Lubricin (150 μg/mL) Eye Drops Versus Sodium Hyaluronate (HA) 0.18% Eye Drops (Vismed®) in Patients with Moderate Dry Eye Disease.
Lambiase A; Sullivan BD; Schmidt TA; Sullivan DA; Jay GD; Truitt ER; Bruscolini A; Sacchetti M; Mantelli F
Ocul Surf; 2017 Jan; 15(1):77-87. PubMed ID: 27614318
[TBL] [Abstract][Full Text] [Related]
2. A randomized, multicenter phase 3 study comparing 2% rebamipide (OPC-12759) with 0.1% sodium hyaluronate in the treatment of dry eye.
Kinoshita S; Oshiden K; Awamura S; Suzuki H; Nakamichi N; Yokoi N;
Ophthalmology; 2013 Jun; 120(6):1158-65. PubMed ID: 23490326
[TBL] [Abstract][Full Text] [Related]
3. Sodium hyaluronate 0.30% ocular gel versus sodium hyaluronate 0.18% eye drop in the treatment of moderate to severe dry eye disease.
Calonge M; Sahyoun M; Baillif S; Gain P; Paw E; Mearza A; Cochener B
Eur J Ophthalmol; 2023 Jan; 33(1):188-195. PubMed ID: 35450456
[TBL] [Abstract][Full Text] [Related]
4. Lifitegrast for the Treatment of Dry Eye Disease: Results of a Phase III, Randomized, Double-Masked, Placebo-Controlled Trial (OPUS-3).
Holland EJ; Luchs J; Karpecki PM; Nichols KK; Jackson MA; Sall K; Tauber J; Roy M; Raychaudhuri A; Shojaei A
Ophthalmology; 2017 Jan; 124(1):53-60. PubMed ID: 28079022
[TBL] [Abstract][Full Text] [Related]
5. Sodium hyaluronate eye drops in the treatment of dry eye disease: an open label, uncontrolled, multi-centre trial.
Cheema A; Aziz T; Mirza SA; Siddiqi A; Maheshwary N; Khan MA
J Ayub Med Coll Abbottabad; 2012; 24(3-4):14-6. PubMed ID: 24669598
[TBL] [Abstract][Full Text] [Related]
6. Osmoprotectants, carboxymethylcellulose and hyaluronic acid multi-ingredient eye drop: a randomised controlled trial in moderate to severe dry eye.
Labetoulle M; Chiambaretta F; Shirlaw A; Leaback R; Baudouin C
Eye (Lond); 2017 Oct; 31(10):1409-1416. PubMed ID: 28452989
[TBL] [Abstract][Full Text] [Related]
7. A randomized, controlled study of the efficacy and safety of a new eyedrop formulation for moderate to severe dry eye syndrome.
Chiambaretta F; Doan S; Labetoulle M; Rocher N; Fekih LE; Messaoud R; Khairallah M; Baudouin C;
Eur J Ophthalmol; 2017 Jan; 27(1):1-9. PubMed ID: 27445067
[TBL] [Abstract][Full Text] [Related]
8. Effect of Single Instillation of Two Hyaluronic Acid-Based Topical Lubricants on Tear Film Thickness in Patients with Dry Eye Syndrome.
Szegedi S; Scheschy U; Schmidl D; Aranha Dos Santos V; Stegmann H; Adzhemian N; Fondi K; Bata AM; Werkmeister RM; Couderc C; Schmetterer L; Garhofer G
J Ocul Pharmacol Ther; 2018 Nov; 34(9):605-611. PubMed ID: 30325687
[TBL] [Abstract][Full Text] [Related]
9. Efficacy in patients with dry eye after treatment with a new lubricant eye drop formulation.
Davitt WF; Bloomenstein M; Christensen M; Martin AE
J Ocul Pharmacol Ther; 2010 Aug; 26(4):347-53. PubMed ID: 20653478
[TBL] [Abstract][Full Text] [Related]
10. Improving ocular surface comfort in contact lens wearers.
Fernández-Jimenez E; Diz-Arias E; Peral A
Cont Lens Anterior Eye; 2022 Jun; 45(3):101544. PubMed ID: 34840071
[TBL] [Abstract][Full Text] [Related]
11. A comparison of cyclosporine 0.05% ophthalmic emulsion versus vehicle in Chinese patients with moderate to severe dry eye disease: an eight-week, multicenter, randomized, double-blind, parallel-group trial.
Chen M; Gong L; Sun X; Xie H; Zhang Y; Zou L; Qu J; Li Y; He J
J Ocul Pharmacol Ther; 2010 Aug; 26(4):361-6. PubMed ID: 20698799
[TBL] [Abstract][Full Text] [Related]
12. Lifitegrast Ophthalmic Solution 5.0% versus Placebo for Treatment of Dry Eye Disease: Results of the Randomized Phase III OPUS-2 Study.
Tauber J; Karpecki P; Latkany R; Luchs J; Martel J; Sall K; Raychaudhuri A; Smith V; Semba CP;
Ophthalmology; 2015 Dec; 122(12):2423-31. PubMed ID: 26365210
[TBL] [Abstract][Full Text] [Related]
13. NOV03 for Dry Eye Disease Associated with Meibomian Gland Dysfunction: Results of the Randomized Phase 3 GOBI Study.
Tauber J; Berdy GJ; Wirta DL; Krösser S; Vittitow JL;
Ophthalmology; 2023 May; 130(5):516-524. PubMed ID: 36574848
[TBL] [Abstract][Full Text] [Related]
14. Tear osmolarity measurement using the TearLab Osmolarity System in the assessment of dry eye treatment effectiveness.
Benelli U; Nardi M; Posarelli C; Albert TG
Cont Lens Anterior Eye; 2010 Apr; 33(2):61-7. PubMed ID: 20153684
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of 0.3% carbomer gel compared to placebo in patients with moderate-to-severe dry eye syndrome.
Sullivan LJ; McCurrach F; Lee S; Taylor HR; Rolando M; Marechal-Courtois C; Creuzot-Garcher C; Easty DL; Karabatsas C; Bingh Hoh M; Faschinger C; Laroche L
Ophthalmology; 1997 Sep; 104(9):1402-8. PubMed ID: 9307633
[TBL] [Abstract][Full Text] [Related]
16. Clinical Effects and Safety of 3% Diquafosol Ophthalmic Solution for Patients With Dry Eye After Cataract Surgery: A Randomized Controlled Trial.
Park DH; Chung JK; Seo DR; Lee SJ
Am J Ophthalmol; 2016 Mar; 163():122-131.e2. PubMed ID: 26685791
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of hypotonic 0.18% sodium hyaluronate eye drops in patients with dry eye disease.
Lee HS; Ji YS; Yoon KC
Cornea; 2014 Sep; 33(9):946-51. PubMed ID: 24915018
[TBL] [Abstract][Full Text] [Related]
18. Efficacy, Safety, and Tolerability of a Novel Cyclosporine, a Formulation for Dry Eye Disease: A Multicenter Phase II Clinical Study.
Peng WY; Chen RX; Dai H; Zhu L; Li Y; Gao ZQ; Li XY; Zhou SY
Clin Ther; 2021 Mar; 43(3):613-628. PubMed ID: 33546885
[TBL] [Abstract][Full Text] [Related]
19. Results of a Multicenter, Randomized, Double-Masked, Placebo-Controlled Clinical Study of the Efficacy and Safety of Visomitin Eye Drops in Patients with Dry Eye Syndrome.
Brzheskiy VV; Efimova EL; Vorontsova TN; Alekseev VN; Gusarevich OG; Shaidurova KN; Ryabtseva AA; Andryukhina OM; Kamenskikh TG; Sumarokova ES; Miljudin ES; Egorov EA; Lebedev OI; Surov AV; Korol AR; Nasinnyk IO; Bezditko PA; Muzhychuk OP; Vygodin VA; Yani EV; Savchenko AY; Karger EM; Fedorkin ON; Mironov AN; Ostapenko V; Popeko NA; Skulachev VP; Skulachev MV
Adv Ther; 2015 Dec; 32(12):1263-79. PubMed ID: 26660938
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of objective optical quality measured by double-pass aberrometry in patients with moderate dry eye: Normal saline vs. artificial tears: A pilot study].
Vandermeer G; Chamy Y; Pisella PJ
J Fr Ophtalmol; 2018 Mar; 41(3):238-245. PubMed ID: 29573863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
